The National Institute for Health and Care Excellence (NICE) has recommended cladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS).

The Merck KGaA collaborated with actress and patient advocate Selma Blair for the I’m Ready campaign. When EMD Serono embarked on a campaign to empower patients living with relapsing multiple ...

Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...

Michael Castagna became CEO of MannKind and joined its board of directors in 2017, bringing 25+ years’ experience in ...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ... She’ll now continue to share her experiences through EMD Serono’s ongoing “I’m Ready” campaign.

Ralston brings more than 25 years of experience providing strategic Market Access and HEOR solutions.

Dr Reddy's, Merck Serono in pact to develop biotech drugs Germany's Merck KGaA, have entered into a partnership to co-develop a portfolio of biosimilar compounds (biotechnology drugs) in the ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

Coronado Research, a consultancy-led, professional services organisation providing support to pharmaceutical, biotechnology, and medical device companies, has appointed Stephen Ralston as EVP Market ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...